Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegileridine vs sufentanil for postoperative analgesia after VATS
ChiCTR2600121230Phase 4Not yet recruiting
- Sponsor
- Renmin Hospital of Wuhan University
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tegileridine in postoperative pain (2 arms), sponsored by Renmin Hospital of Wuhan University. Primary endpoint: AUC-NRS48 (area under the curve of postoperative NRS pain scores over 48 hours). Planned start Mar 2026; status: not yet recruiting.
02
Drugs
tegileridine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600121230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600121230.